Concepedia

Publication | Closed Access

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

DOI

268

Citations

19

References

2005

Year

Keith Dredge, Rebecca Horsfall, Simon P. Robinson, Linghua Zhang, Ling Lu, Yang Tang, Michael A. Shirley, George W. Muller, Peter Schäfer, David Stirling,
Microvascular Research

References

YearCitations

Page 1